Drawing for IO

USPTO serial 97853264

IO

Reviewed by CopyMark Law Group

Reg. 7699387Status 700Registered
Filing date
Status date
Registration date
Feb 18, 2025
Examiner
TANNER, MICHAEL R
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Melanie Howard

Melanie Howard LOEB & LOEB LLP10100 SANTA MONICA BOULEVARD, SUITE 2200LOS ANGELES, CA 90067United States

Goods and services

ClassDescriptionStatusFirst use
005Vaccines for the prevention and treatment of cancerACTIVE—
042Scientific research for medical purposes for others relating to vaccines for the prevention and treatment of cancer; Pharmaceutical research and development services for others for vaccines for the prevention and treatment of cancer; medical and pharmacological research services for others concerning vaccines for the prevention and treatment of cancer; research and development in the pharmaceutical and biotechnology fields for others concerning vaccines for the prevention and treatment of cancer; providing medical and scientific research information in the fields of pharmaceutical and clinical trials concerning vaccines for the prevention and treatment of cancer; scientific research in the nature of conducting clinical trials for others featuring vaccines for the prevention and treatment of cancer; providing medical research information, and pharmaceutical research advisory and consultancy services in the field of vaccines for the prevention and treatment of cancer; Research and development and consultation related thereto in the field of vaccines for the prevention and treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 18, 2025NRCSNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 18, 2025R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Jan 27, 2025CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Nov 21, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Nov 21, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 21, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 21, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 1, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 1, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 1, 2024ALIEASSIGNED TO LIE—
Jun 10, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 5, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Mar 5, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Dec 22, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 22, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 22, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2023DOCKASSIGNED TO EXAMINER—
Jul 27, 2023TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jul 27, 2023PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 14, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 27, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance